pubmed-article:9223444 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9223444 | lifeskim:mentions | umls-concept:C0379710 | lld:lifeskim |
pubmed-article:9223444 | lifeskim:mentions | umls-concept:C0907532 | lld:lifeskim |
pubmed-article:9223444 | lifeskim:mentions | umls-concept:C0011740 | lld:lifeskim |
pubmed-article:9223444 | lifeskim:mentions | umls-concept:C1519726 | lld:lifeskim |
pubmed-article:9223444 | lifeskim:mentions | umls-concept:C0037628 | lld:lifeskim |
pubmed-article:9223444 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
pubmed-article:9223444 | lifeskim:mentions | umls-concept:C0443264 | lld:lifeskim |
pubmed-article:9223444 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:9223444 | pubmed:dateCreated | 1997-8-7 | lld:pubmed |
pubmed-article:9223444 | pubmed:abstractText | Caveolin-1 and endothelial nitric oxide synthase (eNOS) are associated within endothelial caveolae. We have shown previously that eNOS is translocated to the detergent-insoluble, cytoskeletal fraction of bovine aortic endothelial cells (BAEC) in response to bradykinin (BK)-stimulation or tyrosine phosphatase inhibition. In the present study, we have examined whether caveolin-1 is similarly translocated in response to these or other stimuli. Exposure of BAEC to the eNOS-activating agonists, BK, histamine, or ATP produces transient increases in the amounts of detergent-insoluble caveolin-1. Increases in insolubility are blocked by tyrosine kinase inhibitors and are potently mimicked by tyrosine phosphatase inhibitors. Increased insolubility is accompanied by an increased association of caveolin-1 with eNOS and inhibition of eNOS catalytic activity. Agonist-activation of eNOS in endothelial cells thus appears to involve tyrosine phosphorylation-dependent changes in the interaction of eNOS with caveolin-1. Increased interaction of eNOS with caveolin-1 may deactivate the enzyme subsequent to its activation by Ca2+/calmodulin. | lld:pubmed |
pubmed-article:9223444 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:language | eng | lld:pubmed |
pubmed-article:9223444 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9223444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9223444 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9223444 | pubmed:month | Jul | lld:pubmed |
pubmed-article:9223444 | pubmed:issn | 0006-291X | lld:pubmed |
pubmed-article:9223444 | pubmed:author | pubmed-author:VenemaV JVJ | lld:pubmed |
pubmed-article:9223444 | pubmed:author | pubmed-author:JuHH | lld:pubmed |
pubmed-article:9223444 | pubmed:author | pubmed-author:VenemaR CRC | lld:pubmed |
pubmed-article:9223444 | pubmed:author | pubmed-author:MarreroM BMB | lld:pubmed |
pubmed-article:9223444 | pubmed:author | pubmed-author:ZouRR | lld:pubmed |
pubmed-article:9223444 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9223444 | pubmed:day | 9 | lld:pubmed |
pubmed-article:9223444 | pubmed:volume | 236 | lld:pubmed |
pubmed-article:9223444 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9223444 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9223444 | pubmed:pagination | 155-61 | lld:pubmed |
pubmed-article:9223444 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:meshHeading | pubmed-meshheading:9223444-... | lld:pubmed |
pubmed-article:9223444 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9223444 | pubmed:articleTitle | Caveolin-1 detergent solubility and association with endothelial nitric oxide synthase is modulated by tyrosine phosphorylation. | lld:pubmed |
pubmed-article:9223444 | pubmed:affiliation | Vascular Biology Center, Department of Pediatrics, Medical College of Georgia, Augusta 30912, USA. | lld:pubmed |
pubmed-article:9223444 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9223444 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:9223444 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9223444 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9223444 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9223444 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9223444 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9223444 | lld:pubmed |